Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908517 · ClinicalTrials.gov registry record · NA
Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study
A NA study, sponsored by East Carolina University.
- Completed
- Registry status
- NA
- Development phase
- 522
- Enrollment target
NCT01908517: Completed NA study, sponsored by East Carolina University.
NCT01908517 is a NA study that has completed, run by East Carolina University. The registered enrollment target is 522 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01908517, a NA study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- NA
- Development phase
- 522 participants
- Enrollment target
Study Summary
There has been very limited research that has looked at electronic reminders (text messages) and its effectiveness in adherence to vaccination among low-income minority populations. Results have shown that text messages, among low-income parents and adolescents who were identified as having a cellphone, is an effective strategy to increase the likelihood of adolescent vaccination adherence. Hard copy and electronic messaging reminders have also been proven to be effective when coupled with other prevention strategies for immunizations for influenza and pneumococcal pneumonia and screening for colon, breast, and cervical cancer in adults. Additionally, Merck and Co. recommend electronic reminders in their patient compliance program as a key strategy for adherence. To our knowledge, this community-based pilot intervention study will be the first to assess electronic reminders and HPV vaccine initiation and adherence among rural uninsured and Medicaid populations. The investigators hypothesize that adolescent whose parents who receive the intervention will be more likely to initiate HPV vaccination and be compliant at 3 months and at 7 months as compared to the control group.
Primary Outcome
Vaccine adherence will be measured using the CDC's guidelines which state that the second dose be given one to two months after the first, and the third dose be given six months after the first dose.
Interventions
- BEHAVIORAL HPV Vaccine Electronic Reminders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 522 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT01908517 record still lists
NCT01908517 is an interventional study that assigns participants to a tested intervention. The registered 522 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 1 intervention - of which HPV Vaccine Electronic Reminders is the first listed.
NCT01908517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01908517 about?
NCT01908517 is a clinical study titled "Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study". There has been very limited research that has looked at electronic reminders (text messages) and its effectiveness in adherence to vaccination among low-income minority populations. Results have shown that text messages, among low-income parents and adolescents who were identified as having a cellph...
What is the current status of trial NCT01908517?
This trial is currently completed. It is a NA study. The enrollment target is 522 participants. The study started on 2013-08. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01908517?
The interventions under investigation include: HPV Vaccine Electronic Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT01908517?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01908517's enrollment target sits among peer trials
522 189th of 2000 higher than 1,811 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
- NCT06894212 · 522 participants · Phase 3
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia